Tamoxifen in the Prevention of Breast Cancer in Hodgkin's Disease Survivors

NCT00165308 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
29
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Dana-Farber Cancer Institute

Collaborators